pd 98059 and lysophosphatidylcholines

pd 98059 has been researched along with lysophosphatidylcholines in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (15.38)18.2507
2000's10 (76.92)29.6817
2010's1 (7.69)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choy, PC; Geiger, JD; Golfman, LS; Haughey, NJ; Jiang, JY; Lee, D; Wong, JT1
Cieslik, K; Lee, CM; Tang, JL; Wu, KK1
Hirata, Ki; Hotta, H; Ishido, S; Kawashima, S; Rikitake, Y; Ueyama, T; Yamashita, T; Yokoyama, M1
Hirata , K; Inoue, N; Kawashima, S; Kojima, Y; Rikitake, Y; Shimokawa, Y; Takeuchi, S; Yokoyama, M1
Hashimoto, N; Hayashida, K; Kataoka, H; Kita, T; Kume, N; Minami, M; Miyamoto, S; Morimoto, M; Ueno, Y1
Benedict, CR; Katagiri, T; Pakala, R; Watanabe, T2
Chisolm, GM; Gerber, CE; Kottke-Marchant, K; Mukhopadhyay, C; Murugesan, G; Ransohoff, RM; Sandhya Rani, MR1
Bassa, BV; Ganji, SH; Kamanna, VS; Noh, JW; Roh, DD; Shin, MK1
Kadonosono, K; Kamei, J; Ohnaka, K; Tanaka, S; Utsunomiya, H; Yamakawa, T1
Fan, Z; Jiang, Y; Liu, J; Liu, N; Liu, Z; Long, Y; Mo, Y; Qin, Q; Wang, J; Xing, F; Zhao, K1
Burkholder, TJ1
Baolin, L; Jinghua, F; Junna, S; Kang, L; Lin, L; Min, Z1

Other Studies

13 other study(ies) available for pd 98059 and lysophosphatidylcholines

ArticleYear
Lysophosphatidylcholine induces arachidonic acid release and calcium overload in cardiac myoblastic H9c2 cells.
    Journal of lipid research, 1999, Volume: 40, Issue:10

    Topics: Animals; Arachidonic Acid; Arachidonic Acids; Calcium; Cell Line; Enzyme Inhibitors; Flavonoids; Indoles; Isoquinolines; Kinetics; Lysophosphatidylcholines; Myocardium; Nimodipine; Phospholipases A; Protein Kinase C; Rats; Staurosporine; Structure-Activity Relationship; Sulfonamides

1999
Transcriptional regulation of endothelial nitric-oxide synthase by an interaction between casein kinase 2 and protein phosphatase 2A.
    The Journal of biological chemistry, 1999, Dec-03, Volume: 274, Issue:49

    Topics: Casein Kinase II; Cell Nucleus; Cells, Cultured; Dichlororibofuranosylbenzimidazole; Endothelium, Vascular; Enzyme Inhibitors; Flavonoids; Gene Expression Regulation, Enzymologic; Humans; Luciferases; Lysophosphatidylcholines; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nucleic Acid Synthesis Inhibitors; Phosphoprotein Phosphatases; Promoter Regions, Genetic; Protein Binding; Protein Phosphatase 2; Protein Serine-Threonine Kinases; Signal Transduction; Sp1 Transcription Factor; Time Factors; Transcription, Genetic

1999
Lysophosphatidylcholine inhibits endothelial cell migration and proliferation via inhibition of the extracellular signal-regulated kinase pathway.
    Arteriosclerosis, thrombosis, and vascular biology, 2000, Volume: 20, Issue:4

    Topics: Animals; Aorta; Cattle; Cell Division; Cell Movement; Cells, Cultured; Endothelium, Vascular; Enzyme Activation; Enzyme Inhibitors; Fibroblast Growth Factor 2; Flavonoids; Gene Expression; Lysophosphatidylcholines; MAP Kinase Kinase 1; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Mutation; Phosphotyrosine; Protein Serine-Threonine Kinases; ras Proteins; Signal Transduction; Type C Phospholipases

2000
Signaling mechanism underlying COX-2 induction by lysophosphatidylcholine.
    Biochemical and biophysical research communications, 2001, Volume: 281, Issue:5

    Topics: Activating Transcription Factor 1; Animals; Cattle; Cells, Cultured; Cyclic AMP Response Element-Binding Protein; Cyclooxygenase 2; DNA-Binding Proteins; Endothelium, Vascular; Enzyme Induction; Enzyme Inhibitors; Flavonoids; Imidazoles; Indoles; Isoenzymes; Isoquinolines; Lysophosphatidylcholines; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Prostaglandin-Endoperoxide Synthases; Pyridines; RNA, Messenger; Sulfonamides; Transcription Factors; Up-Regulation

2001
Lysophosphatidylcholine induces early growth response factor-1 expression and activates the core promoter of PDGF-A chain in vascular endothelial cells.
    Arteriosclerosis, thrombosis, and vascular biology, 2001, Volume: 21, Issue:5

    Topics: Animals; Cattle; Cell Nucleus; Cells, Cultured; DNA-Binding Proteins; Endothelium, Vascular; Enzyme Inhibitors; Flavonoids; Imidazoles; Kinetics; Lysophosphatidylcholines; MAP Kinase Kinase 1; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase Kinases; Platelet-Derived Growth Factor; Promoter Regions, Genetic; Protein Serine-Threonine Kinases; Pyridines; RNA, Messenger; Transcription Factors; Transcriptional Activation

2001
Mildly oxidized low-density lipoprotein acts synergistically with angiotensin II in inducing vascular smooth muscle cell proliferation.
    Journal of hypertension, 2001, Volume: 19, Issue:6

    Topics: Acetylcysteine; Aldehydes; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antioxidants; Benzimidazoles; Biphenyl Compounds; Cardiovascular Diseases; Cell Division; Cells, Cultured; DNA; Drug Synergism; Flavonoids; Humans; Hydrogen Peroxide; Lipoproteins, LDL; Lysophosphatidylcholines; Muscle, Smooth, Vascular; Probucol; Rabbits; Receptor, Angiotensin, Type 1; Tetrazoles; Tyrphostins

2001
Lysophosphatidylcholine is a major contributor to the synergistic effect of mildly oxidized low-density lipoprotein with endothelin-1 on vascular smooth muscle cell proliferation.
    Journal of cardiovascular pharmacology, 2002, Volume: 39, Issue:3

    Topics: Acetylcysteine; Aldehydes; Animals; Aorta, Thoracic; Cell Count; Cell Division; Cells, Cultured; DNA; Endothelin Receptor Antagonists; Endothelin-1; Flavonoids; Free Radical Scavengers; Growth Inhibitors; Hydrogen Peroxide; Lipoproteins, LDL; Lysophosphatidylcholines; Male; Mitogen-Activated Protein Kinase Kinases; Muscle, Smooth, Vascular; NADPH Oxidases; Onium Compounds; Oxidants; Peptides, Cyclic; Rabbits; Reactive Oxygen Species

2002
Lysophosphatidylcholine regulates human microvascular endothelial cell expression of chemokines.
    Journal of molecular and cellular cardiology, 2003, Volume: 35, Issue:11

    Topics: Aorta; Cells, Cultured; Chemokine CCL2; Chemokine CCL5; Chemokines; Chemotaxis; Chromones; Dose-Response Relationship, Drug; Drug Synergism; Endothelium, Vascular; Enzyme Inhibitors; Flavonoids; Humans; Imidazoles; Interleukin-8; Lysophosphatidylcholines; Mitogen-Activated Protein Kinases; Morpholines; p38 Mitogen-Activated Protein Kinases; Pertussis Toxin; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Pulmonary Artery; Pyridines; Signal Transduction; Time Factors; Tumor Necrosis Factor-alpha; Umbilical Veins

2003
Lysophosphatidylcholine stimulates EGF receptor activation and mesangial cell proliferation: regulatory role of Src and PKC.
    Biochimica et biophysica acta, 2007, Volume: 1771, Issue:11

    Topics: Cell Proliferation; Cells, Cultured; Enzyme Inhibitors; ErbB Receptors; Flavonoids; Humans; Indoles; Lysophosphatidylcholines; Maleimides; MAP Kinase Signaling System; Mesangial Cells; Protein Kinase C; Quinazolines; src-Family Kinases; Tyrphostins

2007
Cyclooxygenase-2 induction by lysophosphatidylcholine in cultured rat vascular smooth muscle cells: involvement of the p38MAPK pathway.
    Biomedical research (Tokyo, Japan), 2008, Volume: 29, Issue:1

    Topics: Animals; Cells, Cultured; Culture Media, Serum-Free; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Enzyme Induction; Flavonoids; Imidazoles; Lysophosphatidylcholines; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Nitrobenzenes; p38 Mitogen-Activated Protein Kinases; Pyridines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sulfonamides

2008
Lysophosphatidylcholine up-regulates human endothelial nitric oxide synthase gene transactivity by c-Jun N-terminal kinase signalling pathway.
    Journal of cellular and molecular medicine, 2009, Volume: 13, Issue:6

    Topics: Blotting, Western; Cell Line; DNA Probes; Electrophoretic Mobility Shift Assay; Enzyme Inhibitors; Flavonoids; Green Fluorescent Proteins; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Lysophosphatidylcholines; Microscopy, Fluorescence; Mitogen-Activated Protein Kinases; Nitric Oxide Synthase Type III; Phosphorylation; Promoter Regions, Genetic; Protein Binding; Pyridines; Signal Transduction; Sp1 Transcription Factor; Transcription Factor AP-1; Transcriptional Activation; Up-Regulation

2009
Stretch-induced ERK2 phosphorylation requires PLA2 activity in skeletal myotubes.
    Biochemical and biophysical research communications, 2009, Aug-14, Volume: 386, Issue:1

    Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinases; Cells, Cultured; Enzyme Activation; Flavonoids; Genistein; Lysophosphatidylcholines; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Muscle Fibers, Skeletal; Muscle, Skeletal; Phospholipase A2 Inhibitors; Phospholipases A2; Phosphorylation; Protein Kinase Inhibitors; Stress, Mechanical

2009
Resveratrol restores lysophosphatidylcholine-induced loss of endothelium-dependent relaxation in rat aorta tissue coinciding with inhibition of extracellular-signal-regulated protein kinase activation.
    Phytotherapy research : PTR, 2010, Volume: 24, Issue:12

    Topics: Animals; Aorta, Thoracic; Biological Factors; Cells, Cultured; Cyclooxygenase 1; Endothelial Cells; Endothelium-Dependent Relaxing Factors; Endothelium, Vascular; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Gene Expression Regulation; Humans; In Vitro Techniques; Lysophosphatidylcholines; Male; Membrane Proteins; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes

2010
chemdatabank.com